Outset Medical, Inc. Common Stock (OM) Stock
Key stats
- Market cap
- $78.70M
- Price / Earnings ratio
- -1.1x
- EPS (TTM)
- -$3.78
- Volume
- Loading
- 52-week high
- $8.51
- 52-week low
- $2.84
Source: third-party data provider, as of November 13, 2026
Compare with OM
Recent news

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
OM

Outset Medical Q2 Earnings Call Highlights
Outset Medical Q2 Earnings Call Highlights
OM

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
OM

Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
OM
Technical indicators
- RSI 14
- 52.95
- MACD 12/26/9
- 0.09
- EMA 9 of MACD
- 0.11
- MACD histogram
- -0.02
- SMA 50
- $3.75
- Price above SMA 50
- EMA 50
- $4.00
- Price above EMA 50
- SMA 200
- $4.11
- Price above SMA 200
- EMA 200
- $4.09
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
OM

Outset Medical Q2 Earnings Call Highlights
Outset Medical Q2 Earnings Call Highlights
OM

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
OM

Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
OM

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
OM

Outset Medical Q1 Earnings Call Highlights
Outset Medical Q1 Earnings Call Highlights
OM

Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
OM

OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System
OM

Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
OM

3 MedTech Stocks to Buy for Healthy Gains
3 MedTech Stocks to Buy for Healthy Gains
OM
About Outset Medical, Inc. Common Stock
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Leslie L. Trigg | President, CEO & Chairman | 1971 |
| Ms. Renee M. Gaeta | CFO, Principal Financial Officer & Principal Accounting Officer | 1981 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 52.95
- MACD 12/26/9
- 0.09
- EMA 9 of MACD
- 0.11
- MACD histogram
- -0.02
- SMA 50
- $3.75
- Price above SMA 50
- EMA 50
- $4.00
- Price above EMA 50
- SMA 200
- $4.11
- Price above SMA 200
- EMA 200
- $4.09
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -9.4 | +2.7 | ||||||||||
| 2022 | -21.3 | +15.9 | +4.1 | -25.8 | -40.6 | -29.0 | -1.3 | -6.7 | -9.4 | -5.6 | +45.4 | +16.7 |
| 2023 | +12.9 | -19.6 | -18.5 | -4.3 | +9.2 | +0.2 | -0.5 | -33.2 | -21.6 | -65.2 | +39.4 | -4.9 |
| 2024 | -46.1 | +5.7 | -28.2 | +21.6 | +30.9 | +0.8 | -3.8 | -84.9 | +28.3 | -9.8 | +46.9 | +22.6 |
| 2025 | -31.6 | -9.6 | +10.4 | -2.5 | +57.3 | +7.9 | -22.5 | -7.5 | +2.8 | -6.4 | -65.0 | -12.1 |
| 2026 | +35.4 | -29.8 | +7.6 | +11.2 | +12.2 | -12.0 | -10.4 | -23.4 | -17.6 | +7.5 | +3.7 |



